Skip to content

DYNAGEN™ EL ICD DR D152Recalls & reported problems

Boston Scientific Corporation · Implantable Cardioverter Defibrillator DR · Class 3 · Implant

All models of DYNAGEN EL ICD DR (2)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Quick summary

This Boston Scientific Dynagen EL ICD defibrillator has 1,194 adverse event reports, including 12 deaths and 749 injuries. Many reports describe inappropriate shocks, pacing problems, and sensing problems, and some describe high electrical resistance in the leads or batteries running out early. Many reports mention infections, and some mention sepsis. No recalls name this device. Reports in the last 12 months (97) are fewer than in the 12 months before (154).

AI-generated from the FDA records on this page and checked automatically against the numbers below. Read the details before relying on it.

Adverse event reports
1,208
Deaths reported
12
Injuries reported
755
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1,208 adverse event reports that list this exact device (DI 00802526534324), received between Apr 21, 2016 and Sep 25, 2026 — classified as 12 deaths, 755 injuries, 441 malfunctions.

The most frequently reported specific device problem is “Pacing Problem” (252 reports).

14 other recalls cover devices cleared under the same FDA submission (P960040); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 24 reportsDec 2023: 18 reportsJan 2024: 21 reportsFeb 2024: 17 reportsMar 2024: 15 reportsApr 2024: 15 reportsMay 2024: 8 reportsJun 2024: 15 reportsJul 2024: 12 reportsAug 2024: 11 reportsSep 2024: 10 reportsOct 2024: 15 reportsNov 2024: 20 reportsDec 2024: 14 reportsJan 2025: 11 reportsFeb 2025: 13 reportsMar 2025: 12 reportsApr 2025: 8 reportsMay 2025: 15 reportsJun 2025: 14 reportsJul 2025: 10 reportsAug 2025: 11 reportsSep 2025: 6 reportsOct 2025: 20 reportsNov 2025: 11 reportsDec 2025: 12 reportsJan 2026: 14 reportsFeb 2026: 14 reportsMar 2026: 9 reportsApr 2026: 3 reportsMay 2026: 8 reportsJun 2026: 11 reportsJul 2026: 6 reportsAug 2026: 14 reportsSep 2026: 9 reportsOct 2026: 0 reports20242025202624
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem354
  • Pacing Problem252
  • Inappropriate/Inadequate Shock/Stimulation236
  • Over-Sensing208
  • High impedance190
  • Premature Discharge of Battery100
  • Signal Artifact/Noise84
  • Under-Sensing83

Patient problems

  • No Clinical Signs, Symptoms or Conditions361
  • Unspecified Infection303
  • Electric Shock120
  • Shock from Patient Lead(s)111
  • No Known Impact Or Consequence To Patient100
  • Sepsis93
  • No Consequences Or Impact To Patient43
  • No Code Available41

Recent adverse event reports

The 25 most recent of 1,208 reports, in the reporter's own words as published by the FDA.

  • InjurySep 25, 2026Failure to Convert Rhythm

    Patient problems: Ventricular Fibrillation

    MAUDE report 50898086 ↗
  • InjurySep 24, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation

    It was reported that this implantable cardioverter defibrillator (ICD) delivered inappropriate shocks and anti-tachycardia pacing (ATP) for what appeared to be atrial fibrillation (AF) with rapid ventricular response (RVR). No additional adverse patient effects were reported. This ICD remains in service.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 50882566 ↗
  • MalfunctionSep 23, 2026Failure to Convert Rhythm; Under-Sensing

    It was reported that the patient with this implantable cardioverter defibrillator (ICD) had three separate ventricular tachycardia (VT) episodes and therapy was exhausted in two of the episodes. Additionally, this ICD exhibited undersensing. Technical Services (TS) reviewed the data and noted therapy was appropriate and that there was some rare undersensing. TS noted the undersensing did not impact the time to delivery therapy. No adverse patient effects were reported. This ICD remains in service.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50871534 ↗
  • InjurySep 22, 2026Insufficient Device Problem Information

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50862595 ↗
  • MalfunctionSep 9, 2026Inappropriate/Inadequate Shock/Stimulation; Interrogation Problem

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 50697401 ↗
  • InjurySep 7, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: Pocket Erosion; Purulent Discharge; Unspecified Infection

    MAUDE report 50652160 ↗
  • MalfunctionSep 4, 2026Premature Discharge of Battery

    It was reported that this implantable cardioverter defibrillator (ICD) emitted beeping tones due to the recorded Code 1003, indicating the voltage was too low for the projected remaining capacity. A request was made to have data from this device analyzed. Data analysis showed the battery voltage recently began dropping in an irregular fashion. Device replacement was recommended. As of this time, this ICD remains in service. No adverse patient effects were reported.Additional information indicated that this ICD was explanted and replaced with the same model. No additional adverse patient effects were reported.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50602476 ↗
  • MalfunctionSep 4, 2026Adverse Event Without Identified Device or Use Problem

    Patient problems: Implant Pain

    MAUDE report 50602096 ↗
  • MalfunctionSep 4, 2026High impedance; Over-Sensing

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50600638 ↗
  • InjuryAug 25, 2026High impedance

    It was reported that this implantable cardioverter defibrillator (ICD) system exhibited an alert for high pacing impedance measurements above 3000 Ohms. This device has been explanted and replaced. No additional adverse patient effects were reported. This device has not been returned for analysis.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50425856 ↗
  • InjuryAug 24, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation

    It was reported that this implantable cardioverter defibrillator (ICD) delivered one burst of anti-tachycardia pacing (ATP) and seven shocks as inappropriate therapy for atrial fibrillation (AF) with rapid ventricular response (RVR). Technical Services (TS) was consulted and discussed stored as well as programming options based on the patients rhythm. Additionally, the patient reported that the device felt warm and hot intermittently. TS performed an analysis of device battery and it was determined the battery was depleting normally, with power consumption stable. The device function is normal since high power events would be reflected in power consumption or monitoring voltage, with both normal and no device issues noted. This device remains in service. No additional adverse patient effects were reported.

    Patient problems: Discomfort; Shock from Patient Lead(s)

    MAUDE report 50416011 ↗
  • InjuryAug 21, 2026Adverse Event Without Identified Device or Use Problem

    It was reported that this implantable cardioverter defibrillator (ICD) was explanted with less than a month of use as the patient had swelling in the left arm due to an unknown cause and a subclavian vein thrombosis was suspected. No new device was implanted. No additional adverse patient effects were reported.

    Patient problems: Swelling/ Edema; Thrombosis/Thrombus

    MAUDE report 50360699 ↗
  • MalfunctionAug 20, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation

    It was reported that this implantable cardioverter defibrillator (ICD) delivered nine bursts of anti-tachycardia pacing (ATP) and one shock as inappropriate therapy for a suspected atrial driven rhythm. Technical Services (TS) was consulted and discussed stored data. This device remains in service. No adverse patient effects were reported.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 50351098 ↗
  • InjuryAug 20, 2026Inappropriate/Inadequate Shock/Stimulation

    It was reported that the patient implanted with this implantable cardioverter defibrillator (ICD) received two inappropriate shocks for two episodes of atrial fibrillation (AF) with rapid ventricular response (RVR). Therapy was not exhausted. Technical Services (TS) was consulted about the episodes while the patient was getting an AF ablation. This ICD remains in service. No additional adverse patient effects were reported.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 50349152 ↗
  • MalfunctionAug 19, 2026Over-Sensing

    Patient problems: Insufficient Information

    MAUDE report 50326224 ↗
  • InjuryAug 13, 2026Signal Artifact/Noise

    It was reported that implantable cardioverter defibrillator (ICD) exhibited noisy signals on reviewed electrograms. Technical Services (TS) confirmed the noise on the presenting electrogram. The device was unexpectedly received by Boston Scientific for further analysis. No new device has been implanted. No additional adverse patient effects were reported. This ICD is no longer in service.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50234769 ↗
  • MalfunctionAug 12, 2026Over-Sensing; Pacing Problem; Inappropriate/Inadequate Shock/Stimulation

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 50223120 ↗
  • MalfunctionAug 11, 2026High impedance

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50214636 ↗
  • MalfunctionAug 11, 2026Under-Sensing

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50211012 ↗
  • MalfunctionAug 11, 2026Signal Artifact/Noise; Over-Sensing

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50204422 ↗
  • MalfunctionAug 11, 2026Pacing Problem; Failure to Read Input Signal; Low impedance

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50204134 ↗
  • InjuryAug 4, 2026Over-Sensing; Pacing Problem; Failure to Convert Rhythm; Defibrillation/Stimulation Problem; Inappropriate/Inadequate Shock/Stimulation

    It was reported that this implantable cardioverter defibrillator (ICD) delivered inappropriate anti-tachycardia pacing (ATP) and five electric shocks due to sinus tachycardia. The rate started with a 1:1 rhythm with a high Rhythm ID (RID) match, then RID became negative which led to the inappropriate therapy. The ATP accelerated the ventricular tachycardia (VT) into the ventricular fibrillation (VF) zone. The rhythm went from VF to VT several times during the five shocks. Therapy was exhausted and didn't convert the arrythmia. Also, it was noted there was intermittent atrial oversensing of ventricular signals. Technical Services (TS) recommended reprogramming options. This ICD remains in service. No additional adverse patient effects were reported.

    Patient problems: Shock from Patient Lead(s); Ventricular Fibrillation

    MAUDE report 50133105 ↗
  • MalfunctionAug 4, 2026Premature Discharge of Battery

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 50129766 ↗
  • InjuryJul 31, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation; Under-Sensing

    It was reported that this implantable cardioverter defibrillator (ICD) exhibited undersensing that resulted in three inappropriate shocks and anti-tachycardia pacing (ATP) delivered when not required. Technical Services (TS) was consulted and faxed the results for the health care professional (HCP) to review. This device remains in service. No additional adverse patient effects were reported.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 50100693 ↗
  • InjuryJul 27, 2026Pacing Problem; Inappropriate/Inadequate Shock/Stimulation

    It was reported that this implantable cardioverter defibrillator (ICD) delivered six shocks and several rounds of anti-tachycardia pacing (ATP) for what appeared to be atrial fibrillation (AF) with rapid ventricular response (RVR). Technical Services (TS) was contacted and reviewed the information. This ICD remains in service. No additional adverse patient effects were reported.

    Patient problems: Shock from Patient Lead(s)

    MAUDE report 50047568 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P960040. One submission often covers many models, so check the product and lot details in each record.

  • Z-1670-2022 · Jul 7, 2022 · Open, Classified
    The PRM is intended to be used as part of the ZOOM LATITUDE Programming System to communicate with Boston Scientific implantable pulse generators. The software in use controls all
  • Z-0077-2018 · Oct 4, 2017 · Terminated
    RESONATE EL ICD VR, Model D432, Sterile.
  • Z-0079-2018 · Oct 4, 2017 · Terminated
    VIGILANT X4 CRT-D, Model G247, Sterile. Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) are indicated for patients with heart failure who receive stable optimal pharma
  • Z-0078-2018 · Oct 4, 2017 · Terminated
    RESONATE EL ICD DR, Model D433, Sterile.
  • Z-1555-2010 · Mar 15, 2010 · Terminated
    Boston Scientific CONFIENT, model E030, Implantable Cardioverter Defibrillator (ICD). The CONFIENT Implantable Cardioverter Defibrillator (ICDs) are designed to detect and termina
  • Z-0610-2010 · Dec 1, 2009 · Terminated
    Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models F102, F110, F111. Sterilized using ethyle
  • Z-1621-2009 · Mar 4, 2009 · Terminated
    GUIDANT VITALITY DS VR Model T135 VR; EL Model T127 DR; 2ICD Model T165 DR; 2ICD Model T175 VR; 2EL ICD Model T167 DR; 2 EL ICD Model T177 VR; DS Model T125 DR. Implantable Cardi
  • Z-1513-2008 · Jan 7, 2008 · Terminated
    VITALITY DR+ Implantable Cardioverter Defibrillator (ICD), model 1872
  • Z-1514-2008 · Jan 7, 2008 · Terminated
    VITALITY EL, models T127, T167, T177 Implantable Cardioverter Defibrillator (ICD), pulse-generator, dual Chamber
  • Z-0051-2008 · Mar 16, 2007 · Terminated
    Guidant VITALITY 2 DR/VR (Models T165, T175) and Guidant VITALITY 2 EL DR/VR (Models T167, T177). Implantable Cardioverter Defibrillator, ICD. Guidant Corporation, 4100 Hamline A
  • Z-0050-2008 · Mar 16, 2007 · Terminated
    Guidant VITALITY DS DR/VR (Models T125, T135), Guidant VITALITY EL (Model T127), Guidant VITALITY DR HE (Model T180), Implantable Cardioverter Defibrillators (ICD). Guidant Corpor
  • Z-1297-06 · Jun 24, 2006 · Terminated
    Guidant VENTAK PRIZM VR (model 1860) and VENTAK PRIZM DR (model 1861) Automatic Implantable Cardioverter Defibrillator (AICD), Dual Chamber, Sterilized with gaseous ethylene oxide.
  • Z-1292-06 · May 15, 2006 · Terminated
    Guidant VITALITY 2 (models T165, T175), VITALITY DS (model T125), VITALITY EL (model T135), Implantable Cardioverter Defibrillators (ICD), are designed to detect and terminate ven
  • Z-0828-06 · Apr 7, 2006 · Terminated
    Guidant VITALITY HE Implantable Cardioverter Defibrillator (model T180). Sterile EO. Guidant Corporation, Cardiac Rhythm Management, 4100 Hamline Avenue North, St. Paul, MN 551

Other Implantable cardioverter defibrillator (non-CRT) devices

All Implantable cardioverter defibrillator (non-CRT) devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page